Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City

Detalles Bibliográficos
Autores principales: Saxena, Amit, Engel, Alexis J, Banbury, Brittany, Hasan, Ghadeer, Fraser, Nicola, Zaminski, Devyn, Masson, Mala, Haberman, Rebecca H, Scher, Jose U, Ho, Gary, Law, Jammie, Rackoff, Paula, Tseng, Chung-E, Belmont, H Michael, Clancy, Robert M, Buyon, Jill P, Izmirly, Peter M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275793/
https://www.ncbi.nlm.nih.gov/pubmed/35856060
http://dx.doi.org/10.1016/S2665-9913(22)00190-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275793/
https://www.ncbi.nlm.nih.gov/pubmed/35856060
http://dx.doi.org/10.1016/S2665-9913(22)00190-4

Ejemplares similares